- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
Identification of immune-related genes that predict prognosis and risk of bladder cancer: bioinformatics analysis of TCGA database.Bladder CancerAugust 2, 2021
-
Novel Visualization Methods Assisted Transurethral Resection for Bladder Cancer: An Updated Survival-Based Systematic Review and Meta-Analysis.Bladder CancerAugust 2, 2021
-
Cumulative incidence of ureteroenteric strictures after radical cystectomy in a population-based Swedish cohort.Bladder CancerJuly 30, 2021
-
Incidence trends and survival prediction of urothelial cancer of the bladder: a population-based study.Bladder CancerJuly 30, 2021
-
Epidermal Growth Factor Based Targeted Toxin for the Treatment of Bladder Cancer.Bladder CancerJuly 29, 2021
-
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.Bladder CancerJuly 29, 2021
-
Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands.Bladder CancerJuly 28, 2021
-
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition.Bladder CancerJuly 28, 2021
-
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancerBladder CancerJuly 27, 2021
-
Potential candidates for en bloc resection among patients with primary and recurrent bladder tumours.Bladder CancerJuly 27, 2021
Beyond the Abstracts
-
A miRNA Signature Predicts Benefit from Addition of Hypoxia-Modifying Therapy to Radiation Treatment in Invasive Bladder Cancer-Beyond the Abstract - Beyond the AbstractBladder CancerJuly 29, 2021
-
Oncological Outcomes of High-Grade T1 Non-Muscle-Invasive Bladder Cancer Treatment in Octogenarians - Beyond the AbstractBladder CancerJuly 26, 2021
-
WANTED: The T-cells Responsible for Cancer Immunotherapy - Beyond the AbstractBladder CancerJuly 26, 2021
-
Active Surveillance for Non-Muscle Invasive Bladder Cancer: A Systematic Review and Pooled-Analysis - Beyond the AbstractBladder CancerJuly 22, 2021
-
Macro and Microeconomics of Blue Light Cystoscopy with CYSVIEW® in Non-Muscle Invasive Bladder Cancer - Beyond the AbstractBladder CancerJuly 19, 2021
-
Rapamycin Enhances BCG-Specific γδ T Cells During Intravesical BCG Therapy for Non-Muscle Invasive Bladder Cancer: A Randomized, Double-Blind Study - Beyond the AbstractBladder CancerJuly 13, 2021
-
Pulsed Lasers and Endocorporeal Laser Lithotripsy – Beyond the AbstractBladder CancerJuly 13, 2021
-
First Time Intravesically Administered Trifunctional Antibody Catumaxomab in Patients with Recurrent Non-Muscle Invasive Bladder Cancer – Beyond the AbstractBladder CancerJuly 1, 2021
-
Intermediate- and High-Risk Nonmuscle Invasive Bladder Cancer: Where Do We Stand? - Beyond the AbstractBladder CancerJune 30, 2021
-
Novel Roles of the Androgen Receptor in Bladder Cancer - Beyond the AbstractBladder CancerJune 29, 2021